結核管理の推奨要素を実装している地域におけるMycobacterium tuberculosisの感染拡大
D P Chin1, C M Crane, M Y Diul
1Tuberculosis Control Branch and Microbial Disease Laboratory, California Department of Health Services, Berkeley, USA. chind@chn.wpro.who.int
JAMA
|June 24, 2000
まとめ
進行中のMycobacterium tuberculosisの伝播は,制御措置をとっても結核 (TB) を引き起こします. 早期の診断とよりよい接触者識別は,結核病の発症を予防するために極めて重要です.
科学分野:
- エピデミオロジー エピデミオロジー
- 感染症 感染症は感染症です.
- 公衆衛生は公衆衛生である.
背景:
- 結核 (TB) は,制御の努力にもかかわらず,米国では公衆衛生上の懸念事項であり続けています.
- マイコバクテリア結核の伝播は継続しており,新たな症例が発生しています.
研究 の 目的:
- 特定のM. tuberculosis株から結核病の発症の主な原因を特定する.
- 結核対策を講じられた地域社会における感染ダイナミクスを理解する.
主な方法:
- 都市部のサンフランシスコ・ベイ・エリアのコミュニティで,人口ベースの分子疫学研究が行われました.
- ゲノタイプ化と疫学的な関連付けにより,1996年から1997年の間に,単一のM. tuberculosis株によって引き起こされた結核の73例が特定されました.
主要な成果:
- 特定されたM.結核菌株は,コミュニティ内の結核症例の33%の原因となった.
- 疾患の発症の重要な要因には,接触者を特定できなかったこと (53%),発症源の診断が遅れたこと (27%) および接触者評価/治療に関する問題 (18%) が含まれていた.
- ほとんどの感染 (96%) は,診断前の2年以内に発生しました.
結論:
- 効果的な結核対策には,早期の患者診断と,より徹底した接触者の特定が必要です.
- 結核の継続的な伝播は,既設の結核予防プログラムがある地域でも継続しています.
さらに関連する動画
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
関連する概念動画
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
